COSMO Pharmaceuticals Aktie
WKN DE: A2AJ68 / ISIN: NL0011832936
20.06.2023 07:15:12
|
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
Cosmo Pharmaceuticals N.V.
/ Key word(s): Regulatory Approval
Dublin, Ireland 20 June 2023: COSMO Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (Cosmo) today announced that its partner Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (Sun Pharma) has received marketing authorization (Notice of Compliance) from Health Canada for Winlevi® (clascoterone cream 1%). Winlevi® is the first and only androgen receptor inhibitor indicated for the topical treatment of acne vulgaris (acne) in patients 12 years of age and older, and the newest Health Canada-approved formulation to target the hormonal component of acne for Canadian patients in 40 years. As stated by Abhay Gandhi, North America CEO of Sun Pharma: We are thrilled to provide a new topical treatment option for the millions of Canadians affected by acne. Acne is a highly prevalent dermatological condition, affecting approximately 20 per cent of Canadians. Data shows that acne affects patients health-related quality of life and may increase the risk of depression and anxiety.
About Winlevi® Disclaimer Contact:
End of Media Release |
Language: | English |
Company: | Cosmo Pharmaceuticals N.V. |
Riverside 2, Sir John Rogersons | |
Dublin 2 Dublin | |
Ireland | |
Phone: | + 353 1 817 0370 |
E-mail: | info@cosmopharma.com |
Internet: | https://www.cosmopharma.com/ |
ISIN: | NL0011832936 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1660737 |
End of News | EQS News Service |
|
1660737 20.06.2023 GMT/BST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu COSMO Pharmaceuticals N.V.mehr Nachrichten
05.06.25 |
Gute Stimmung in Zürich: SPI zum Handelsende in Grün (finanzen.at) | |
05.06.25 |
Handel in Zürich: SPI am Donnerstagnachmittag in Rot (finanzen.at) | |
05.06.25 |
Freundlicher Handel in Zürich: SPI bewegt sich im Plus (finanzen.at) | |
05.06.25 |
SPI-Wert COSMO Pharmaceuticals-Aktie: So viel Verlust hätte ein COSMO Pharmaceuticals-Investment von vor 5 Jahren eingebracht (finanzen.at) | |
02.06.25 |
SPI-Wert COSMO Pharmaceuticals-Aktie: COSMO Pharmaceuticals-Dividende verringert sich (finanzen.at) | |
30.05.25 |
Freundlicher Handel: SPI bewegt schlussendlich im Plus (finanzen.at) | |
30.05.25 |
Optimismus in Zürich: SPI am Freitagnachmittag in Grün (finanzen.at) | |
30.05.25 |
Freundlicher Handel: SPI legt mittags zu (finanzen.at) |
Analysen zu COSMO Pharmaceuticals N.V.mehr Analysen
Aktien in diesem Artikel
COSMO Pharmaceuticals N.V. | 62,50 | 2,46% |
|